Capsule: HIV Drug Spat Heats Up and IT Wonks Talk Health Gaps

Welcome to Capsule, where we’ll give you your weekly dose of what to watch out for in the health-care space. Each week reporters Ayanna Alexander and Jacquie Lee get you prepped for the week’s hottest health-care topics.

Jacquie: Gilead has until Thursday to reply to a lawsuit alleging the company is ignoring the federal government’s patent rights for the HIV-prevention drugs Truvada and Descovy. The government claims the Centers for Disease Control and Prevention was instrumental in creating Truvada—the leading HIV-prevention drug—and Descovy, which the FDA recently approved to prevent HIV as well.

Here’s how the federal government sees ...